跳至主要内容
临床试验/NCT05630027
NCT05630027已完成不适用

Soothing and Anti-hair Loss Activity of a Scalp Lotion Containing Piroctone Olamine, 2,4 Diaminopyrimidine Oxide and Vichy Mineralizing Water

Cosmetique Active International1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2019年1月2日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
100
试验地点
1
主要终点
erythema

研究概览

简要总结

Overall, 100 Caucasian subjects participated in this 6-weeks lasting study, AC5+ was applied daily. All subjects had clinically confirmed mild to moderate alopecia and self-declared sensitive scalp. Instrumental assessments included Trans Epidermal Water Loss (TEWL), inflammation markers, clinical assessments included the severity of erythema, inflammation and greasiness. Subjective/Self assessments comprised the intensity of the scalp itch/pruritus and the evaluation of their head hair status (volume, abundance, strength). Same assessments were provided by the investigators.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

接受健康志愿者

入选标准

  • >18 years
  • mild alopecia:
  • female: Ludwig type 1
  • male: Hamilton III to IV type

排除标准

  • Moderate or severe alopecia

结局指标

主要结局

erythema

时间窗: Day 21

on a scale from o=none to 5=severe

inflammation

时间窗: Day 21

on a scale from o=none to 5=severe

Global soothing score

时间窗: Day 21

sum of the symptoms with a score up to 15

greasiness

时间窗: Day 21

on a scale from o=none to 5=severe

次要结局

  • hair quality(Day 21)
  • Squalene monohydroperoxide(Day 21)
  • pruritus(Day 21)
  • burning(Day 21)
  • Inflammation markers(Day 21)
  • stinging(Day 21)
  • scratching(Day 21)
  • Transepidermal water loss(Day 21)
  • squalene(Day 21)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验